Semaglutide is effective in type 2 diabetes and obesity with schizophrenia

被引：0
|
作者：
Kaoru Noda
Takehiro Kato
Nao Nomura
Mayu Sakai
Sodai Kubota
Tokuyuki Hirose
Yanyan Liu
Yoshihiro Takahashi
Ken Takao
Masami Mizuno
Takuo Hirota
Tetsuya Suwa
Yukio Horikawa
Daisuke Yabe
机构：
[1] Gifu University Graduate School of Medicine,Department of Diabetes, Endocrinology and Metabolism
[2] Gifu University Graduate School of Medicine,Department of Rheumatology and Clinical Immunology
[3] Kansai Electric Power Medical Research Institute,Yutaka Seino Distinguished Center for Diabetes Research
[4] Tokai National Higher Education and Research System,Center for Healthcare Information Technology
[5] Kobe University Graduate School of Medicine,Division of Molecular and Metabolic Medicine
来源：
Diabetology International | 2022年 / 13卷
关键词：
GLP-1 receptor agonist; Schizophrenia; Obesity; Type 2 diabetes; Bodyweight;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：693 / 697
页数：4
相关论文
共 50 条
  • [41] Type 2 diabetes in obesity
    Chakaroun, R.
    DIABETOLOGE, 2014, 10 (07): : 581 - 582
  • [42] Obesity and type 2 diabetes
    Waine, C.
    NUTRITION BULLETIN, 2006, 31 (02) : 111 - 114
  • [43] Obesity and type 2 diabetes
    Toplak, Hermann
    Hoppichler, Friedrich
    Wascher, Thomas C.
    Schindler, Karin
    Ludvik, Bernhard
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S196 - S200
  • [44] Glycaemic control and weight loss with semaglutide in type 2 diabetes
    Madsbad, Sten
    Holst, Jens J.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (05): : 315 - +
  • [45] SEMAGLUTIDE DAMPENS RESIDUAL INFLAMMATION IN INDIVIDUALS WITH TYPE 2 DIABETES
    Oostveen, Reindert
    Teunis, Charlotte
    Tzolos, Evangelos
    Kroon, Jeffrey
    Verberne, Hein
    Murphy, Andrew
    Stroes, Erik
    Hanssen, Nordin
    ATHEROSCLEROSIS, 2024, 395
  • [46] Comparison of different doses of tirzepatide and semaglutide in type 2 diabetes
    Kahl, S.
    DIABETOLOGIE, 2022, 18 (06): : 756 - 757
  • [47] The Effects of Semaglutide on β-cell Function in Subjects with Type 2 Diabetes
    Kapitza, Christoph
    Dahl, Kirsten
    Jacobsen, Jacob Bonde
    Axelsen, Mads Buhl
    Flint, Anne
    DIABETES, 2016, 65 : A262 - A263
  • [48] Oral Semaglutide (Rybelsus) for the Treatment of Type 2 Diabetes Mellitus
    Semenya, Afi Mansa
    Wilson, Stephen A.
    AMERICAN FAMILY PHYSICIAN, 2020, 102 (10) : 627 - 628
  • [49] Effect of Semaglutide on Epicardial Adipose Tissue in Type 2 Diabetes
    Manubolu, Venkat Sanjay
    Lakshmanan, Suvasini
    Kinninger, April
    Ahmad, Khadije
    Susarla, Shriraj
    Seok, Hoon J.
    Hamal, Sajad
    Dahal, Suraj
    Roy, Sion K.
    Budoff, Matthew J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (09) : 865 - 867
  • [50] Semaglutide: Review and Place in Therapy for Adults With Type 2 Diabetes
    Goldenberg, Ronald M.
    Steen, Oren
    CANADIAN JOURNAL OF DIABETES, 2019, 43 (02) : 136 - 145
12345